Oct 12 (Reuters) - Promore Pharma AB PROMO.ST :
* PROMORE PHARMA INITIATES VOLUNTARY LIQUIDATION
* BOARD ASSESSES THAT COMPANY'S CASH IS SUFFICIENT UNTIL
MID-DECEMBER 2023
* BOARD HAS, TOGETHER WITH EXTERNAL ADVISORS, EXPLORED
SEVERAL
FINANCING OPTIONS AS WELL AS OPPORTUNITIES FOR VARIOUS FORMS OF
STRATEGIC TRANSACTIONS
* NEGOTIATIONS REGARDING POSSIBLE STRUCTURAL TRANSACTIONS
ARE
ONGOING AND TWO LETTERS OF INTENT HAVE BEEN SIGNED REGARDING
CONCRETE BUSINESS PROPOSALS, BUT NO BINDING AGREEMENTS HAVE BEEN
SIGNED
* BOARD THEREFORE CONSIDERS THAT THERE IS CURRENTLY NO
ACCEPTABLE
ALTERNATIVE TO A DECISION ON VOLUNTARY LIQUIDATION, IN ORDER TO
AVOID A BANKRUPTCY SITUATION IN EVENT THAT A STRUCTURAL
TRANSACTION COULD NOT BE IMPLEMENTED
Source text for Eikon: ID:nMFNPpbrB
Further company coverage: PROMO.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))